India's Ambassador to the United States Taranjit Singh Sandhu on Wednesday (8 July) said that India and US are working together to combat the Covid-19 pandemic and that Ayurveda practitioners and researchers in both the countries are planning to inititate joint clinical trials of Ayurvedic formulations against the novel Coronavirus, reports Times of India.
In a virtual interaction with a group of Indian-American scientists, researchers and academicians, Sandhu said that vast network of institutional engagements have brought the scientific communities in the two countries together.
He further said that institutions in both the countries have been collaborating to promote Ayurveda through joint research, teaching and training programs.
"Ayurvedic practitioners and researchers in both the countries are planning to initiate joint clinical trials of Ayurvedic formulations against Covid-19,” Sandhu was quoted as saying.
“Our scientists have been exchanging knowledge and research resources on this front,” he said.
On the Covid-19 vaccine development, Sandhu said that there were at least three ongoing collaborations between Indian vaccine companies and US-based institutions.
He noted that these collaborations will not only benefit India and US, but will also be beneficial for billions of people around the world.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.